Recorded Presentation from the NCCN Pharmacy Updates: Mycosis Fungoides and Sézary Syndrome: Overview of Systemic Therapy
Pharmacists should be aware of the treatment recommendations for this rare disease type so they can support patients as well as the health care team in making informed treatment decisions. It is also important to be aware of the potential adverse events that can occur with these therapies since pharmacists frequently provide patient education and monitoring related to this in order to avoid severe complications and maximize treatment outcomes.
Category
  • T-Cell Lymphomas
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: CAR-T Therapy in Multiple Myeloma
Pharmacists should be aware of the new data and recommendations surrounding this novel agent and how they relate to improvements in patient survival and quality of life. It is also important to be aware of the potential for unique and potentially severe adverse events that can occur with these therapies.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Liver-Directed and Systemic Therapy Options for Hepatocellular Carcinoma
Incidence and mortality rates for most cancers are declining; however, the incidence and mortality rates for liver cancer are increasing. A thorough understanding of the different approaches to treatment can help clinicians identify the optimal treatment strategy. Keeping clinicians abreast of new developments in the field can better inform clinical decision-making.
Category
  • Hepatobiliary Cancers
  • Hepatocellular Carcinoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Treatment Options for Patients with Bladder Cancer
A number of new treatment options for different stages of bladder cancer are on the horizon, which will make education about the data behind these therapies and how they might be used in clinical practice important. Of interest, a number of treatment options for bacillus Calmette Guérin (BCG)-unresponsive non–muscle invasive bladder cancer (NMIBC) are currently being evaluated in clinical trials, and systemic therapy options for muscle-invasive and metastatic disease have rapidly expanded.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Management of Patients with Non-Metastatic Prostate Cancer
Improved prognostication and risk stratification can help identify patients with localized prostate cancer who may derive greater or lesser absolute benefit from a given treatment, thus preventing over- and under-treatment. Clinicians need to be knowledgeable about newer tools that can improve risk stratification, and they need to understand when these tools have the possibility to change management so that unnecessary testing can be avoided.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Management of Patients with HER2-Negative Breast Cancer
Staying up-to-date with the available treatment options is important to integrate new evidence-based data into their clinical practice, and being familiar with their toxicity profile is important to optimize patient outcomes.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenging Case Review: Breast Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with breast cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
The Future of Telemedicine in Oncology
Education in this area is important because the broad use of telemedicine in oncology was quickly implemented in response to the COVID-19 pandemic. As best practices are being considered, the future of telemedicine in oncology and how reimbursement and legislation will support it, is worthy of discussion.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Plenary Session – The Patient Journey: Access to Cancer Care
This session will focus on how quality cancer care is now available closer to your home, or even in your home. To ensure safe access to cancer care, it is important for those who manage patients with cancer and those with responsibility for patient access to recognize how cancer care has evolved over the last few years and to review current challenges and recommendations for continued improvement in patient access to quality cancer care in the future.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Management of Patients with Aggressive Non-Melanoma Skin Cancers
Even though the prognosis for patients with non-melanoma skin cancer is generally good, there are subsets of patients who are prone to recurrence or regional and distant metastasis. Awareness of aggressive disease features is, thus, crucial to identify such patients. It is also important for clinicians to stay up-to-date on the current treatment options for these patients.
Category
  • Skin Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages